Table of Contents Author Guidelines Submit a Manuscript
Advances in Virology
Volume 2009, Article ID 623969, 9 pages
http://dx.doi.org/10.1155/2009/623969
Review Article

The Mechanism of Budding of Retroviruses from Cell Membranes

Department of Microbiology and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA

Received 6 October 2008; Accepted 18 December 2008

Academic Editor: Eric O. Freed

Copyright © 2009 Andrew Pincetic and Jonathan Leis. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. C. Klein, J. C. Reed, and J. R. Lingappa, “Intracellular destinies: degradation, targeting, assembly, and endocytosis of HIV Gag,” AIDS Reviews, vol. 9, no. 3, pp. 150–161, 2007. View at Google Scholar
  2. M. Tritel and M. D. Resh, “The late stage of human immunodeficiency virus type 1 assembly is an energy-dependent process,” Journal of Virology, vol. 75, no. 12, pp. 5473–5481, 2001. View at Publisher · View at Google Scholar · View at PubMed
  3. H. G. Göttlinger, T. Dorfman, J. G. Sodroski, and W. A. Haseltine, “Effect of mutations affecting the p6 Gag protein on human immunodeficiency virus particle release,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 8, pp. 3195–3199, 1991. View at Publisher · View at Google Scholar
  4. J. W. Wills, C. E. Cameron, C. B. Wilson, Y. Xiang, R. P. Bennett, and J. Leis, “An assembly domain of the Rous sarcoma virus Gag protein required late in budding,” Journal of Virology, vol. 68, no. 10, pp. 6605–6618, 1994. View at Google Scholar
  5. Y. Xiang, C. E. Cameron, J. W. Wills, and J. Leis, “Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain,” Journal of Virology, vol. 70, no. 8, pp. 5695–5700, 1996. View at Google Scholar
  6. M. Huang, J. M. Orenstein, M. A. Martin, and E. O. Freed, “p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease,” Journal of Virology, vol. 69, no. 11, pp. 6810–6818, 1995. View at Google Scholar
  7. E. O. Freed, “Viral late domains,” Journal of Virology, vol. 76, no. 10, pp. 4679–4687, 2002. View at Publisher · View at Google Scholar
  8. A. P. Schmitt, G. P. Leser, E. Morita, W. I. Sundquist, and R. A. Lamb, “Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus,” Journal of Virology, vol. 79, no. 5, pp. 2988–2997, 2005. View at Publisher · View at Google Scholar · View at PubMed
  9. F. Li, C. Chen, B. A. Puffer, and R. C. Montelaro, “Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication,” Journal of Virology, vol. 76, no. 4, pp. 1569–1577, 2002. View at Publisher · View at Google Scholar
  10. D. E. Ott, L. V. Coren, T. D. Gagliardi, and K. Nagashima, “Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1,” Journal of Virology, vol. 79, no. 14, pp. 9038–9045, 2005. View at Publisher · View at Google Scholar · View at PubMed
  11. J. Martin-Serrano, D. Perez-Caballero, and P. D. Bieniasz, “Context-dependent effects of L domains and ubiquitination on viral budding,” Journal of Virology, vol. 78, no. 11, pp. 5554–5563, 2004. View at Publisher · View at Google Scholar · View at PubMed
  12. H.-Y. Chung, E. Morita, U. von Schwedler, B. Müller, H.-G. Kräusslich, and W. I. Sundquist, “NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains,” Journal of Virology, vol. 82, no. 10, pp. 4884–4897, 2008. View at Publisher · View at Google Scholar · View at PubMed
  13. E. Gottwein, J. Bodem, B. Müller, A. Schmechel, H. Zentgraf, and H.-G. Kräusslich, “The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release,” Journal of Virology, vol. 77, no. 17, pp. 9474–9485, 2003. View at Publisher · View at Google Scholar
  14. V. Blot, F. Perugi, B. Gay et al., “Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding,” Journal of Cell Science, vol. 117, no. 11, pp. 2357–2367, 2004. View at Publisher · View at Google Scholar · View at PubMed
  15. B. Strack, A. Calistri, S. Craig, E. Popova, and H. G. Göttlinger, “AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding,” Cell, vol. 114, no. 6, pp. 689–699, 2003. View at Publisher · View at Google Scholar
  16. L. VerPlank, B. Agresta, T. Grassa, A. Kikonyogo, J. Leis, and C. Carter, “Tsg101, the prototype of a class of dominant-negative ubiquitin regulators, binds human immunodeficiency virus type 1 Pr55Gag: the L domain is a determining of binding,” Poceedings of the National Academy of Sciences of the United States of America, vol. 98, pp. 7724–7729, 2001. View at Google Scholar
  17. U. K. von Schwedler, M. Stuchell, B. Müller et al., “The protein network of HIV budding,” Cell, vol. 114, no. 6, pp. 701–713, 2003. View at Publisher · View at Google Scholar
  18. S. Lee, A. Joshi, K. Nagashima, E. O. Freed, and J. H. Hurley, “Structural basis for viral late-domain binding to Alix,” Nature Structural and Molecular Biology, vol. 14, no. 3, pp. 194–199, 2007. View at Publisher · View at Google Scholar · View at PubMed
  19. O. Vincent, L. Rainbow, J. Tilburn, H. N. Arst, Jr., and M. A. Peñalva, “YPXL/I is a protein interaction motif recognized by Aspergillus PalA and its human homologue, AIP1/Alix,” Molecular and Cellular Biology, vol. 23, no. 5, pp. 1647–1655, 2003. View at Publisher · View at Google Scholar
  20. R. D. Fisher, H.-Y. Chung, Q. Zhai, H. Robinson, W. I. Sundquist, and C. P. Hill, “Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding,” Cell, vol. 128, no. 5, pp. 841–852, 2007. View at Publisher · View at Google Scholar · View at PubMed
  21. A. Kikonyogo, F. Bouamr, M. L. Vana et al., “Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for Gag budding from cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 20, pp. 11199–11204, 2001. View at Publisher · View at Google Scholar · View at PubMed
  22. J. Martin-Serrano, S. W. Eastman, W. Chung, and P. D. Bieniasz, “HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway,” Journal of Cell Biology, vol. 168, no. 1, pp. 89–101, 2005. View at Publisher · View at Google Scholar · View at PubMed
  23. J. H. Hurley and S. D. Emr, “The ESCRT complexes: structure and mechanism of a membrane-trafficking network,” Annual Review of Biophysics and Biomolecular Structure, vol. 35, pp. 277–298, 2006. View at Publisher · View at Google Scholar · View at PubMed
  24. M. D. Stuchell-Brereton, J. J. Skalicky, C. Kieffer, M. A. Karren, S. Ghaffarian, and W. I. Sundquist, “ESCRT-III recognition by VPS4 ATPases,” Nature, vol. 449, no. 7163, pp. 740–744, 2007. View at Publisher · View at Google Scholar · View at PubMed
  25. T. Muzioł, E. Pineda-Molina, R. B. Ravelli et al., “Structural basis for budding by the ESCRT-III factor CHMP3,” Developmental Cell, vol. 10, no. 6, pp. 821–830, 2006. View at Publisher · View at Google Scholar · View at PubMed
  26. G. Medina, Y. Zhang, Y. Tang et al., “The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle release through pathways linked by Tsg101,” Traffic, vol. 6, no. 10, pp. 880–894, 2005. View at Publisher · View at Google Scholar · View at PubMed
  27. J. E. Garrus, U. K. von Schwedler, O. W. Pornillos et al., “Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding,” Cell, vol. 107, no. 1, pp. 55–65, 2001. View at Publisher · View at Google Scholar
  28. M. Shehu-Xhilaga, S. Ablan, D. G. Demirov, C. Chen, R. C. Montelaro, and E. O. Freed, “Late domain-dependent inhibition of equine infectious anemia virus budding,” Journal of Virology, vol. 78, no. 2, pp. 724–732, 2004. View at Publisher · View at Google Scholar
  29. M. L. Vana, Y. Tang, A. Chen, G. Medina, C. Carter, and J. Leis, “Role of Nedd4 and ubiquitination of Rous sarcoma virus Gag in budding of virus-like particles from cells,” Journal of Virology, vol. 78, no. 24, pp. 13943–13953, 2004. View at Publisher · View at Google Scholar · View at PubMed
  30. Y. Usami, S. Popov, E. Popova, and H. G. Göttlinger, “Efficient and specific rescue of human immunodeficiency virus type 1 budding defects by a Nedd4-like ubiquitin ligase,” Journal of Virology, vol. 82, no. 10, pp. 4898–4907, 2008. View at Publisher · View at Google Scholar · View at PubMed
  31. G. Medina, A. Pincetic, L. S. Ehrlich et al., “Tsg101 can replace Nedd4 function in ASV Gag release but not membrane targeting,” Virology, vol. 377, no. 1, pp. 30–38, 2008. View at Publisher · View at Google Scholar · View at PubMed
  32. J. Martin-Serrano, T. Zang, and P. D. Bieniasz, “Role of ESCRT-I in retroviral budding,” Journal of Virology, vol. 77, no. 8, pp. 4794–4804, 2003. View at Publisher · View at Google Scholar
  33. M. D. Stuchell, J. E. Garrus, B. Müller et al., “The human endosomal sorting complex required for transport (ESCRT-I) and its role in HIV-1 budding,” The Journal of Biological Chemistry, vol. 279, no. 34, pp. 36059–36071, 2004. View at Publisher · View at Google Scholar · View at PubMed
  34. A. Pincetic, G. Medina, C. Carter, and J. Leis, “Avian sarcoma virus and human immunodeficiency virus, type 1 use different subsets of ESCRT proteins to facilitate the budding process,” The Journal of Biological Chemistry, vol. 283, no. 44, pp. 29822–29830, 2008. View at Publisher · View at Google Scholar · View at PubMed
  35. C. Langelier, U. K. von Schwedler, R. D. Fisher et al., “Human ESCRT-II complex and its role in human immunodeficiency virus type 1 release,” Journal of Virology, vol. 80, no. 19, pp. 9465–9480, 2006. View at Publisher · View at Google Scholar · View at PubMed
  36. S. Shim, L. A. Kimpler, and P. I. Hanson, “Structure/function analysis of four core ESCRT-III proteins reveals common regulatory role for extreme C-terminal domain,” Traffic, vol. 8, no. 8, pp. 1068–1079, 2007. View at Publisher · View at Google Scholar · View at PubMed
  37. A. Zamborlini, Y. Usami, S. R. Radoshitzky, E. Popova, G. Palu, and H. Göttlinger, “Release of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 budding,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 50, pp. 19140–19145, 2006. View at Publisher · View at Google Scholar · View at PubMed
  38. P. I. Hanson, R. Roth, Y. Lin, and J. E. Heuser, “Plasma membrane deformation by circular arrays of ESCRT-III protein filaments,” Journal of Cell Biology, vol. 180, no. 2, pp. 389–402, 2008. View at Publisher · View at Google Scholar · View at PubMed
  39. S. Lata, G. Schoehn, A. Jain et al., “Helical structures of ESCRT-III are disassembled by VPS4,” Science, vol. 321, no. 5894, pp. 1354–1357, 2008. View at Publisher · View at Google Scholar · View at PubMed
  40. S. Ghazi-Tabatabai, S. Saksena, J. M. Short et al., “Structure and disassembly of filaments formed by the ESCRT-III subunit Vps24,” Structure, vol. 16, no. 9, pp. 1345–1356, 2008. View at Publisher · View at Google Scholar · View at PubMed
  41. M. Agromayor and J. Martin-Serrano, “Interaction of AMSH with ESCRT-III and deubiquitination of endosomal cargo,” The Journal of Biological Chemistry, vol. 281, no. 32, pp. 23083–23091, 2006. View at Publisher · View at Google Scholar · View at PubMed
  42. K. Umebayashi, “The roles of ubiquitin and lipids in protein sorting along the endocytic pathway,” Cell Structure and Function, vol. 28, no. 5, pp. 443–453, 2003. View at Publisher · View at Google Scholar
  43. C. E. Futter, L. M. Collinson, J. M. Backer, and C. R. Hopkins, “Human VPS34 is required for internal vesicle formation within multivesicular endosomes,” Journal of Cell Biology, vol. 155, no. 7, pp. 1251–1263, 2001. View at Publisher · View at Google Scholar · View at PubMed
  44. D. Putterman, R. B. Pepinsky, and V. M. Vogt, “Ubiquitin in avian leukosis virus particles,” Virology, vol. 176, no. 2, pp. 633–637, 1990. View at Publisher · View at Google Scholar
  45. D. E. Ott, L. V. Coren, T. D. Copeland et al., “Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus,” Journal of Virology, vol. 72, no. 4, pp. 2962–2968, 1998. View at Google Scholar
  46. D. E. Ott, L. V. Coren, R. C. Sowder, II, J. Adams, and U. Schubert, “Retroviruses have differing requirements for proteasome function in the budding process,” Journal of Virology, vol. 77, no. 6, pp. 3384–3393, 2003. View at Publisher · View at Google Scholar
  47. U. Schubert, D. E. Ott, E. N. Chertova et al., “Proteasome inhibition interferes with Gag polyprotein processing, release, and maturation of HIV-1 and HIV-2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 24, pp. 13057–13062, 2000. View at Publisher · View at Google Scholar · View at PubMed
  48. A. Patnaik, V. Chau, and J. W. Wills, “Ubiquitin is part of the retrovirus budding machinery,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 24, pp. 13069–13074, 2000. View at Publisher · View at Google Scholar · View at PubMed
  49. E. Gottwein, S. Jäger, A. Habermann, and H.-G. Kräusslich, “Cumulative mutations of ubiquitin acceptor sites in human immunodeficiency virus type 1 Gag cause a late budding defect,” Journal of Virology, vol. 80, no. 13, pp. 6267–6275, 2006. View at Publisher · View at Google Scholar · View at PubMed
  50. J. L. Spidel, R. C. Craven, C. B. Wilson et al., “Lysines close to the Rous sarcoma virus late domain critical for budding,” Journal of Virology, vol. 78, no. 19, pp. 10606–10616, 2004. View at Publisher · View at Google Scholar · View at PubMed
  51. G. Heidecker, P. A. Lloyd, F. Soheilian, K. Nagashima, and D. Derse, “The role of WWP1-Gag interaction and Gag ubiquitination in assembly and release of human T-cell leukemia virus type 1,” Journal of Virology, vol. 81, no. 18, pp. 9769–9777, 2007. View at Publisher · View at Google Scholar · View at PubMed
  52. B. Strack, A. Calistri, and H. G. Göttlinger, “Late assembly domain function can exhibit context dependence and involves ubiquitin residues implicated in endocytosis,” Journal of Virology, vol. 76, no. 11, pp. 5472–5479, 2002. View at Publisher · View at Google Scholar
  53. O. Pornillos, S. L. Alam, R. L. Rich, D. G. Myszka, D. R. Davis, and W. I. Sundquist, “Structure and functional interactions of the Tsg101 UEV domain,” The EMBO Journal, vol. 21, no. 10, pp. 2397–2406, 2002. View at Publisher · View at Google Scholar · View at PubMed
  54. A. Goff, L. S. Ehrlich, S. N. Cohen, and C. A. Carter, “Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release,” Journal of Virology, vol. 77, no. 17, pp. 9173–9182, 2003. View at Publisher · View at Google Scholar
  55. A. Joshi, U. Munshi, S. D. Ablan, K. Nagashima, and E. O. Freed, “Functional replacement of a retroviral late domain by ubiquitin fusion,” Traffic, vol. 9, no. 11, pp. 1972–1983, 2008. View at Publisher · View at Google Scholar · View at PubMed
  56. M. Zhadina, M. O. McClure, M. C. Johnson, and P. D. Bieniasz, “Ubiquitin-dependent virus particle budding without viral protein ubiquitination,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 50, pp. 20031–20036, 2007. View at Publisher · View at Google Scholar · View at PubMed
  57. P. A. Randazzo, T. Terui, S. Sturch, H. M. Fales, A. G. Ferrige, and R. A. Kahn, “The myristoylated amino terminus of ADP-ribosylation factor 1 is a phospholipid- and GTP-sensitive switch,” The Journal of Biological Chemistry, vol. 270, no. 24, pp. 14809–14815, 1995. View at Publisher · View at Google Scholar
  58. M. Gangal, T. Clifford, J. Deich, X. Cheng, S. S. Taylor, and D. A. Johnson, “Mobilization of the A-kinase N-myristate through an isoform-specific intermolecular switch,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 22, pp. 12394–12399, 1999. View at Publisher · View at Google Scholar
  59. P. Spearman, R. Horton, L. Ratner, and I. Kuli-Zade, “Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism,” Journal of Virology, vol. 71, no. 9, pp. 6582–6592, 1997. View at Google Scholar
  60. D. Perez-Caballero, T. Hatziioannou, J. Martin-Serrano, and P. D. Bieniasz, “Human immunodeficiency virus type 1 matrix inhibits and confers cooperativity on Gag precursor-membrane interactions,” Journal of Virology, vol. 78, no. 17, pp. 9560–9563, 2004. View at Publisher · View at Google Scholar · View at PubMed
  61. A. Ono, D. Demirov, and E. O. Freed, “Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding,” Journal of Virology, vol. 74, no. 11, pp. 5142–5150, 2000. View at Publisher · View at Google Scholar
  62. A. Ono, J. M. Orenstein, and E. O. Freed, “Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly,” Journal of Virology, vol. 74, no. 6, pp. 2855–2866, 2000. View at Publisher · View at Google Scholar
  63. A. Ono, S. D. Ablan, S. J. Lockett, K. Nagashima, and E. O. Freed, “Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 41, pp. 14889–14894, 2004. View at Publisher · View at Google Scholar · View at PubMed
  64. V. Chukkapalli, I. B. Hogue, V. Boyko, W.-S. Hu, and A. Ono, “Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient Gag membrane binding,” Journal of Virology, vol. 82, no. 5, pp. 2405–2417, 2008. View at Publisher · View at Google Scholar · View at PubMed
  65. K. Chen, I. Bachtiar, G. Piszczek, F. Bouamr, C. Carter, and N. Tjandra, “Solution NMR characterizations of oligomerization and dynamics of equine infectious anemia virus matrix protein and its interaction with PIP2,” Biochemistry, vol. 47, no. 7, pp. 1928–1937, 2008. View at Publisher · View at Google Scholar · View at PubMed
  66. J. S. Saad, J. Miller, J. Tai, A. Kim, R. H. Ghanam, and M. F. Summers, “Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 30, pp. 11364–11369, 2006. View at Publisher · View at Google Scholar · View at PubMed
  67. A. Figueiredo, T. J. Hope, and J. Leis, unpublished observation.
  68. M. Vidal, P. Mangeat, and D. Hoekstra, “Aggregation reroutes molecules from a recycling to a vesicle-mediated secretion pathway during reticulocyte maturation,” Journal of Cell Science, vol. 110, no. 16, pp. 1867–1877, 1997. View at Google Scholar
  69. J. Willem, M. ter Beest, G. Scherphof, and D. Hoekstra, “A non-exchangeable fluorescent phospholipid anolog as a membrane traffic marker of the endocytic pathway,” European Journal of Cell Biology, vol. 53, no. 1, pp. 173–184, 1990. View at Google Scholar